LE
Lexaria Bioscience Corp.
LEXX · NASDAQ
$3.19 -1.85% (-$0.06)
1M -69.26%
Market Cap $5.27M
P/E Ratio -
Div. Yield -
ROE 160.72%
Bulios Fair Price
$2.24
29.8% downside
Trenutna cena
$3.19
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LEXX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 27.17x
P/B 1.11x
P/E N/A
Growth
78 /100
Growing Rev. growth 40.34%
Book val. growth 27.82%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 3,985.58%
Op. margin 3,973.16%
Quality
0 /100
Poor ROIC 174.06%
ROE 160.72%
ROA 161.71%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 10.60x
Int. coverage N/A
Stability
22 /100
Unstable Beta 0.34x
Rev. volatility 58.41%
EPS volatility 47.46%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LEXX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard C. Christopher
Employees
7
Headquarters
Kelowna
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report